Orum Therapeutics오름테라퓨틱
475830 · KOSDAQ · ₩475830 · 오름테라퓨틱
₩16,070▼ ₩40 (0.25%)End-of-day · Oct 27, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Gross margin | — | — | — |
| Operating margin | −161,817.8% | −219,651.4% | −39.9% |
| Net margin | 45,646.4% | −178,105.4% | −27.5% |
Growth (year on year)
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Revenue growth | +72.1% | −99.9% | — |
| Operating income growth | −26.8% | −521.0% | — |
| Net income growth | +144.1% | −631.2% | — |
Returns
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Return on equity | 11.7% | −33.2% | −4.7% |
| Return on assets | 8.0% | −26.0% | −3.7% |
Leverage and liquidity
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Liabilities to equity | 57.0% | 29.4% | 26.3% |
| Net debt to equity | −56.7% | 6.4% | −16.2% |
| Current ratio | 312.5% | 860.9% | 384.5% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Orum Therapeutics / 오름테라퓨틱 / 475830 / KRX:475830
Source: KRX statistical information